Article Type
Changed
Thu, 01/10/2019 - 13:52
Display Headline
Solitary Nodule on the Proximal Nail Fold

The Diagnosis: Superficial Acral Fibromyxoma

A shave biopsy revealed an uninvolved grenz zone and mildly cellular spindle cell dermal proliferation in a collagenous and myxoid background (Figure 1). Spindle cells were seen in a myxoid background among dense coarse collagen (Figure 2A). Spindle cells also were seen in a myxoid background with mast cells and capillary network (Figure 2B). Histopathologic examination of the biopsy specimen revealed spindle cells that were diffusely positive for CD34 (Figure 3); focally positive for epithelial membrane antigen; and negative for melanocytic markers, smooth muscle markers, and cytokeratin. A diagnosis of superficial acral fibromyxoma (SAFM) was made based on clinical, histopathologic, and immunohistochemical findings.

Figure1
Figure 1. Superficial acral fibromyxoma with an uninvolved grenz zone and mildly cellular spindle cell dermal proliferation in a collagenous and myxoid background (H&E, original magnification ×40).

Figure2
Figure 2. Superficial acral fibromyxoma with spindle cells seen in a myxoid background among dense coarse collagen (A) as well as with mast cells and capillary network (B)(H&E, original magnifications ×200 and ×400).

Figure3
Figure 3. Superficial acral fibromyxoma immunohistochemical staining showed spindle cells that were diffusely positive for CD34 (original magnification ×40).

Superficial acral fibromyxomas, also known as digital fibromyxomas, are soft, slow-growing tumors that have a predilection for subungual or periungual regions of the hands and feet. Superficial acral fibromyxomas most frequently occur on the hallux and rarely occur on the ankle or leg. They can present as nodular, dome-shaped, polyploid, or verrucous masses. They can be soft to firm, gelatinous or solid, off-white to gray-white and can have fasciculate cut surfaces. Superficial acral fibromyxomas can be either painful or painless and present with a deformed nail in 9% of cases. Superficial acral fibromyxoma is a superficial lesion with frequent infiltration of the dermal collagen and subcutaneous tissue and may even erode or infiltrate into the underlying bone in rare cases.1-4 Although SAFMs are rare tumors, documented cases of SAFM have been reported at an increasing rate since the first published report by Fetsch et al2 in 2001.

Patients often delay seeking medical treatment and present with a solitary mass that has been slowly growing for months to years. In a study of 124 patients, Hollmann et al1 found that symptoms exist for a mean of 35 months and present with a small mass with a mean tumor size of 1.7 cm before biopsy or excision. Although the age range is broad, SAFM mostly affects middle-aged adults (median age, 49 years).1 Hollmann et al1 also reported a male predominance (1.3:1 ratio), and preexisting local trauma is reported in 25% of cases.2-4

The differential for SAFM should include dermatofibroma, keloid, dermatofibrosarcoma protuberans, acquired digital fibrokeratoma, infantile digital fibromatosis, neurolemmoma, sclerosing perineurioma, superficial angiomyxoma, low-grade fibromyxoid sarcoma, and acral myxoinflammatory fibroblastic sarcoma.1-4

Superficial acral fibromyxomas are composed of CD34+ spindle or stellate-shaped cells that are embedded in a myxoid and/or dense hyalinized collagenous stroma in a random or loosely fascicular growth pattern. The spindle or stellate-shaped cells in SAFMs also have been found to be focally positive for epithelial membrane antigen and CD99. Lesions have accentuated microvasculature and increased mast cells.5-8

Conservative management is reasonable, but patients presenting with persistent pain and/or local deformity should be definitively treated with complete excision and follow-up. Hollmann et al1 found that 24% of tumors recurred locally upon incomplete excision after a mean interval of 27 months. All recurrent tumors had positive margins at excision or initial biopsy.1 To date, no reports of tumors metastasizing have been documented.1-4

References
  1. Hollmann TJ, Bovée JV, Fletcher CD. Digital fibromyxoma (superficial acral fibromyxoma): a detailed characterization of 124 cases. Am J Surg Pathol. 2012;36:789-798.
  2. Fetsch JF, Laskin WB, Miettinen M. Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Hum Pathol. 2001;32:704-714.
  3. Al-Daraji WI, Miettinen M. Superficial acral fibromyxoma: a clinicopathological analysis of 32 tumors including 4 in the heel. J Cutan Pathol. 2008;35:1020-1026.
  4. Ashby-Richardson H, Rogers GS, Stadecker MJ. Superficial acral fibromyxoma: an overview. Arch Pathol Lab Med. 2011;135:1064-1066.
  5. Quaba O, Evans A, Al-Nafussi AA, et al. Superficial acral fibromyxoma. Br J Plast Surg. 2005;58:561-564.
  6. Oteo-Alvaro A, Meizoso T, Scarpellini A, et al. Superficial acral fibromyxoma of the toe, with erosion of the distal phalanx: a clinical report. Arch Orthop Trauma Surg. 2008;128:271-274.
  7. Meyerle J, Keller RA, Krivda SJ. Superficial acral fibromyxoma of the index finger. J Am Acad Dermatol. 2004;50:134-136.
  8. Kazakov DV, Mentzel T, Buro G, et al. Superficial acral fibromyxoma: report of two cases. Dermatology. 2002;205:285-288.
Article PDF
Author and Disclosure Information

Dr. Choi was from and Dr. Fernandez is from the Yale School of Medicine, New Haven, Connecticut. Dr. Choi currently is from the University of Southern California Keck School of Medicine, Los Angeles. Dr. Sloan is from the University of Connecticut School of Medicine, Farmington.

The authors report no conflict of interest.

Correspondence: David E. Choi, MD (David.Choi2@med.usc.edu).

Issue
Cutis - 102(1)
Publications
Topics
Page Number
E21-E23
Sections
Author and Disclosure Information

Dr. Choi was from and Dr. Fernandez is from the Yale School of Medicine, New Haven, Connecticut. Dr. Choi currently is from the University of Southern California Keck School of Medicine, Los Angeles. Dr. Sloan is from the University of Connecticut School of Medicine, Farmington.

The authors report no conflict of interest.

Correspondence: David E. Choi, MD (David.Choi2@med.usc.edu).

Author and Disclosure Information

Dr. Choi was from and Dr. Fernandez is from the Yale School of Medicine, New Haven, Connecticut. Dr. Choi currently is from the University of Southern California Keck School of Medicine, Los Angeles. Dr. Sloan is from the University of Connecticut School of Medicine, Farmington.

The authors report no conflict of interest.

Correspondence: David E. Choi, MD (David.Choi2@med.usc.edu).

Article PDF
Article PDF
Related Articles

The Diagnosis: Superficial Acral Fibromyxoma

A shave biopsy revealed an uninvolved grenz zone and mildly cellular spindle cell dermal proliferation in a collagenous and myxoid background (Figure 1). Spindle cells were seen in a myxoid background among dense coarse collagen (Figure 2A). Spindle cells also were seen in a myxoid background with mast cells and capillary network (Figure 2B). Histopathologic examination of the biopsy specimen revealed spindle cells that were diffusely positive for CD34 (Figure 3); focally positive for epithelial membrane antigen; and negative for melanocytic markers, smooth muscle markers, and cytokeratin. A diagnosis of superficial acral fibromyxoma (SAFM) was made based on clinical, histopathologic, and immunohistochemical findings.

Figure1
Figure 1. Superficial acral fibromyxoma with an uninvolved grenz zone and mildly cellular spindle cell dermal proliferation in a collagenous and myxoid background (H&E, original magnification ×40).

Figure2
Figure 2. Superficial acral fibromyxoma with spindle cells seen in a myxoid background among dense coarse collagen (A) as well as with mast cells and capillary network (B)(H&E, original magnifications ×200 and ×400).

Figure3
Figure 3. Superficial acral fibromyxoma immunohistochemical staining showed spindle cells that were diffusely positive for CD34 (original magnification ×40).

Superficial acral fibromyxomas, also known as digital fibromyxomas, are soft, slow-growing tumors that have a predilection for subungual or periungual regions of the hands and feet. Superficial acral fibromyxomas most frequently occur on the hallux and rarely occur on the ankle or leg. They can present as nodular, dome-shaped, polyploid, or verrucous masses. They can be soft to firm, gelatinous or solid, off-white to gray-white and can have fasciculate cut surfaces. Superficial acral fibromyxomas can be either painful or painless and present with a deformed nail in 9% of cases. Superficial acral fibromyxoma is a superficial lesion with frequent infiltration of the dermal collagen and subcutaneous tissue and may even erode or infiltrate into the underlying bone in rare cases.1-4 Although SAFMs are rare tumors, documented cases of SAFM have been reported at an increasing rate since the first published report by Fetsch et al2 in 2001.

Patients often delay seeking medical treatment and present with a solitary mass that has been slowly growing for months to years. In a study of 124 patients, Hollmann et al1 found that symptoms exist for a mean of 35 months and present with a small mass with a mean tumor size of 1.7 cm before biopsy or excision. Although the age range is broad, SAFM mostly affects middle-aged adults (median age, 49 years).1 Hollmann et al1 also reported a male predominance (1.3:1 ratio), and preexisting local trauma is reported in 25% of cases.2-4

The differential for SAFM should include dermatofibroma, keloid, dermatofibrosarcoma protuberans, acquired digital fibrokeratoma, infantile digital fibromatosis, neurolemmoma, sclerosing perineurioma, superficial angiomyxoma, low-grade fibromyxoid sarcoma, and acral myxoinflammatory fibroblastic sarcoma.1-4

Superficial acral fibromyxomas are composed of CD34+ spindle or stellate-shaped cells that are embedded in a myxoid and/or dense hyalinized collagenous stroma in a random or loosely fascicular growth pattern. The spindle or stellate-shaped cells in SAFMs also have been found to be focally positive for epithelial membrane antigen and CD99. Lesions have accentuated microvasculature and increased mast cells.5-8

Conservative management is reasonable, but patients presenting with persistent pain and/or local deformity should be definitively treated with complete excision and follow-up. Hollmann et al1 found that 24% of tumors recurred locally upon incomplete excision after a mean interval of 27 months. All recurrent tumors had positive margins at excision or initial biopsy.1 To date, no reports of tumors metastasizing have been documented.1-4

The Diagnosis: Superficial Acral Fibromyxoma

A shave biopsy revealed an uninvolved grenz zone and mildly cellular spindle cell dermal proliferation in a collagenous and myxoid background (Figure 1). Spindle cells were seen in a myxoid background among dense coarse collagen (Figure 2A). Spindle cells also were seen in a myxoid background with mast cells and capillary network (Figure 2B). Histopathologic examination of the biopsy specimen revealed spindle cells that were diffusely positive for CD34 (Figure 3); focally positive for epithelial membrane antigen; and negative for melanocytic markers, smooth muscle markers, and cytokeratin. A diagnosis of superficial acral fibromyxoma (SAFM) was made based on clinical, histopathologic, and immunohistochemical findings.

Figure1
Figure 1. Superficial acral fibromyxoma with an uninvolved grenz zone and mildly cellular spindle cell dermal proliferation in a collagenous and myxoid background (H&E, original magnification ×40).

Figure2
Figure 2. Superficial acral fibromyxoma with spindle cells seen in a myxoid background among dense coarse collagen (A) as well as with mast cells and capillary network (B)(H&E, original magnifications ×200 and ×400).

Figure3
Figure 3. Superficial acral fibromyxoma immunohistochemical staining showed spindle cells that were diffusely positive for CD34 (original magnification ×40).

Superficial acral fibromyxomas, also known as digital fibromyxomas, are soft, slow-growing tumors that have a predilection for subungual or periungual regions of the hands and feet. Superficial acral fibromyxomas most frequently occur on the hallux and rarely occur on the ankle or leg. They can present as nodular, dome-shaped, polyploid, or verrucous masses. They can be soft to firm, gelatinous or solid, off-white to gray-white and can have fasciculate cut surfaces. Superficial acral fibromyxomas can be either painful or painless and present with a deformed nail in 9% of cases. Superficial acral fibromyxoma is a superficial lesion with frequent infiltration of the dermal collagen and subcutaneous tissue and may even erode or infiltrate into the underlying bone in rare cases.1-4 Although SAFMs are rare tumors, documented cases of SAFM have been reported at an increasing rate since the first published report by Fetsch et al2 in 2001.

Patients often delay seeking medical treatment and present with a solitary mass that has been slowly growing for months to years. In a study of 124 patients, Hollmann et al1 found that symptoms exist for a mean of 35 months and present with a small mass with a mean tumor size of 1.7 cm before biopsy or excision. Although the age range is broad, SAFM mostly affects middle-aged adults (median age, 49 years).1 Hollmann et al1 also reported a male predominance (1.3:1 ratio), and preexisting local trauma is reported in 25% of cases.2-4

The differential for SAFM should include dermatofibroma, keloid, dermatofibrosarcoma protuberans, acquired digital fibrokeratoma, infantile digital fibromatosis, neurolemmoma, sclerosing perineurioma, superficial angiomyxoma, low-grade fibromyxoid sarcoma, and acral myxoinflammatory fibroblastic sarcoma.1-4

Superficial acral fibromyxomas are composed of CD34+ spindle or stellate-shaped cells that are embedded in a myxoid and/or dense hyalinized collagenous stroma in a random or loosely fascicular growth pattern. The spindle or stellate-shaped cells in SAFMs also have been found to be focally positive for epithelial membrane antigen and CD99. Lesions have accentuated microvasculature and increased mast cells.5-8

Conservative management is reasonable, but patients presenting with persistent pain and/or local deformity should be definitively treated with complete excision and follow-up. Hollmann et al1 found that 24% of tumors recurred locally upon incomplete excision after a mean interval of 27 months. All recurrent tumors had positive margins at excision or initial biopsy.1 To date, no reports of tumors metastasizing have been documented.1-4

References
  1. Hollmann TJ, Bovée JV, Fletcher CD. Digital fibromyxoma (superficial acral fibromyxoma): a detailed characterization of 124 cases. Am J Surg Pathol. 2012;36:789-798.
  2. Fetsch JF, Laskin WB, Miettinen M. Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Hum Pathol. 2001;32:704-714.
  3. Al-Daraji WI, Miettinen M. Superficial acral fibromyxoma: a clinicopathological analysis of 32 tumors including 4 in the heel. J Cutan Pathol. 2008;35:1020-1026.
  4. Ashby-Richardson H, Rogers GS, Stadecker MJ. Superficial acral fibromyxoma: an overview. Arch Pathol Lab Med. 2011;135:1064-1066.
  5. Quaba O, Evans A, Al-Nafussi AA, et al. Superficial acral fibromyxoma. Br J Plast Surg. 2005;58:561-564.
  6. Oteo-Alvaro A, Meizoso T, Scarpellini A, et al. Superficial acral fibromyxoma of the toe, with erosion of the distal phalanx: a clinical report. Arch Orthop Trauma Surg. 2008;128:271-274.
  7. Meyerle J, Keller RA, Krivda SJ. Superficial acral fibromyxoma of the index finger. J Am Acad Dermatol. 2004;50:134-136.
  8. Kazakov DV, Mentzel T, Buro G, et al. Superficial acral fibromyxoma: report of two cases. Dermatology. 2002;205:285-288.
References
  1. Hollmann TJ, Bovée JV, Fletcher CD. Digital fibromyxoma (superficial acral fibromyxoma): a detailed characterization of 124 cases. Am J Surg Pathol. 2012;36:789-798.
  2. Fetsch JF, Laskin WB, Miettinen M. Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Hum Pathol. 2001;32:704-714.
  3. Al-Daraji WI, Miettinen M. Superficial acral fibromyxoma: a clinicopathological analysis of 32 tumors including 4 in the heel. J Cutan Pathol. 2008;35:1020-1026.
  4. Ashby-Richardson H, Rogers GS, Stadecker MJ. Superficial acral fibromyxoma: an overview. Arch Pathol Lab Med. 2011;135:1064-1066.
  5. Quaba O, Evans A, Al-Nafussi AA, et al. Superficial acral fibromyxoma. Br J Plast Surg. 2005;58:561-564.
  6. Oteo-Alvaro A, Meizoso T, Scarpellini A, et al. Superficial acral fibromyxoma of the toe, with erosion of the distal phalanx: a clinical report. Arch Orthop Trauma Surg. 2008;128:271-274.
  7. Meyerle J, Keller RA, Krivda SJ. Superficial acral fibromyxoma of the index finger. J Am Acad Dermatol. 2004;50:134-136.
  8. Kazakov DV, Mentzel T, Buro G, et al. Superficial acral fibromyxoma: report of two cases. Dermatology. 2002;205:285-288.
Issue
Cutis - 102(1)
Issue
Cutis - 102(1)
Page Number
E21-E23
Page Number
E21-E23
Publications
Publications
Topics
Article Type
Display Headline
Solitary Nodule on the Proximal Nail Fold
Display Headline
Solitary Nodule on the Proximal Nail Fold
Sections
Questionnaire Body

quiz_image

A 62-year-old man presented for evaluation of a slowly growing, nonpainful nodule on the first proximal toenail fold of the right foot of 6 years' duration. He reported that the nail plate of the affected toe was thickened and malaligned. He denied a history of trauma. Physical examination revealed a 2.0×1.6-cm, flesh-colored, nontender, well-defined, rubbery nodule with prominent overlying tortuous telangiectases on the medial aspect of the first proximal toenail fold of the right foot. The associated nail plate was yellow, thickened, and angled laterally into the second toe. Radiograph of the right hallux identified a soft tissue density contiguous with the dorsal aspect of the distal portion of the phalanx. There was no evidence of bony involvement. A shave saucerization biopsy specimen was obtained and sent for hematoxylin and eosin and immunohistochemical staining. The spindle cells were diffusely positive for CD34.

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 07/31/2018 - 11:00
Un-Gate On Date
Tue, 07/31/2018 - 11:00
Use ProPublica
CFC Schedule Remove Status
Tue, 07/31/2018 - 11:00
Article PDF Media